SCHEMBL21416951

SCHEMBL21416951

CCNc1cc(C(F)(F)F)ccc1NC(=O)CN(CC)CC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.49
▸ MAPT P10636 4/20 0.49
▸ HPGD P15428 3/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ LCK P06239 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ MAPK14 Q16539 1/20 0.47
▸ LMNA P02545 3/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ MC4R P32245 1/20 0.42
▸ SCN4A P35499 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26945217 0.85 ALDH1A1 (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL5502180 0.83 ALDH1A1 (0.50) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL5497733 0.71 HPGD (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL13497792 0.71 FABP4 (0.45) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL3894930 0.71 LIPC (0.66) ALDH1A1MAPTHPGDCYP2C19GAA
SCHEMBL21166537 0.70 STAT3 (0.44) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL13497790 0.70 CYP1A2 (0.44) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL5265322 0.70 LIPC (0.50) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL14015041 0.69 VDR (0.45) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL13498234 0.69 CCR2 (0.42) MEN1KMT2ALMNAPKMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2019-10-02 — — EP disclosed
Send feedback